Category Entrepreneurship, ICT and Innovation

ai

India- USA: AI and Digital Economy Partnership 2025

The relationship between the United States and India has entered a new era, where Artificial Intelligence (AI) and the digital economy are becoming the key drivers of cooperation. The Government of India initiated the National AI Mission in March 2024, with a budget of ₹10,300 crore. The mission aims at the development of a large-scale computing infrastructure, the development of in-country created models of Artificial Intelligence like Bharat Gen, the development of semiconductor manufacturing, and the nurturing of Artificial Intelligence talent through the IndiaAI Future Skills programme.

Service Plus (2012): Metadata-based E-service Delivery Framework

Service Plus (2012): Metadata-based E-service Delivery Framework

Modernising public service delivery is essential for enhancing governance and improving citizen engagement. In line with this objective, ServicePlus, a comprehensive platform launched in 2012 as part of the Panchayat Enterprise Suite (PES) under the E-Panchayat Mission Mode Project (MMP), has emerged as a transformative solution.

Copy of Copy of Copy of Policy Update

Assessing India’s Digital Personal Data Protection Act, 2023: Policy Implications and Future Outlook

India is a rapidly digitalising  state with over 954.40 million users. The reach of internet services is immense, with various sectors like healthcare, banking, education and finance adopting the digital platforms to dispense their services.

Department of Pharmaceuticals,2008

Ministry of Chemicals and Fertilizers: Department of Pharmaceuticals,2008

Vision: “To make India the largest global provider of quality medicines at reasonable prices”.

The Department of Pharmaceuticals was established on July 1, 2008, under the Ministry of Chemicals & Fertilizers with the objective of providing greater focus on the development of the pharmaceutical sector in India. The Department plays a crucial role in ensuring the availability of affordable medicines, regulating pricing, encouraging research and development, protecting intellectual property rights, and fulfilling international commitments in the pharmaceutical domain.

Talk to Us